Translated automatically – community improvements welcome.
Remoxipride
Remoxipride is an atypical antipsychotic from the class of benzamides, primarily acting as a dopamine D2 receptor antagonist. It has been used for the treatment of schizophrenia and is characterized by selective inhibition of dopamine D2 receptors. Due to side effects such as seizures, its clinical use has been restricted. The substance primarily affects dopaminergic signaling pathways and exhibits a moderate side effect profile.
Mechanism of Action
- Dopaminantagonismus
Names / Identifiers
IUPAC: Remoxipride
Mechanism of Action
Remoxipride wirkt als Antagonist an Dopaminrezeptoren, insbesondere D2-Rezeptoren, und hat auch Affinität zu bestimmten Serotoninrezeptoren.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Do not use in known hypersensitivity to Remoxipride.
- Caution in patients with cardiovascular diseases.
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Sedierung, Gewichtszunahme und extrapyramidale Symptome.
Safer Use
- Start at a low dose.
- Consider regular medical check-ups.
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other antipsychotics.
- Caution with concurrent alcohol consumption.
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.